Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine
- PMID: 7649968
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine
Abstract
Drug development in psychiatry has evolved from a process dependent on chance discovery to one based on rationally targeting specific mechanisms of action believed to be important in the pathophysiology underlying psychiatric syndromes. Antidepressant pharmacotherapy is the first area to have substantially benefited from this evolution. Serotonin selective reuptake inhibitors (SSRIs) were the first class of psychiatric medications developed based on such molecular targeting. Nefazodone is a new antidepressant that combines blockade of the serotonin-2 receptor with serotonin uptake inhibition. Perhaps as a result of this dual action, nefazodone caused fewer complaints of nervousness (e.g., agitation, anxiety), insomnia, and tremors and a higher incidence of confusion, dizziness, and vision disturbance than do other advanced generation antidepressants based on several different ways of assessing the relative incidence of these adverse effects. Reports of sexual dysfunction on nefazodone and bupropion treatment were lower than on treatment with other recently released antidepressants.
Similar articles
-
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.J Affect Disord. 1998 Dec;51(3):237-54. doi: 10.1016/s0165-0327(98)00222-5. J Affect Disord. 1998. PMID: 10333980 Review.
-
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.Br J Clin Pharmacol. 1997 Jun;43(6):619-26. doi: 10.1046/j.1365-2125.1997.00591.x. Br J Clin Pharmacol. 1997. PMID: 9205822 Free PMC article.
-
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.J Clin Psychiatry. 2001 Apr;62(4):256-60. J Clin Psychiatry. 2001. PMID: 11379839
-
Evaluating the tolerability of the newer antidepressants.J Nerv Ment Dis. 1999 Feb;187(2):96-101. doi: 10.1097/00005053-199902000-00005. J Nerv Ment Dis. 1999. PMID: 10067949
-
[New antidepressive agents].Union Med Can. 1995 Nov;124(3):8-13. Union Med Can. 1995. PMID: 8560639 Review. French. No abstract available.
Cited by
-
Prescribing patterns for nursing home residents in the US. The reality and the vision.Drugs Aging. 1997 Oct;11(4):255-60. doi: 10.2165/00002512-199711040-00001. Drugs Aging. 1997. PMID: 9342555 Review.
-
The economics of selective serotonin reuptake inhibitors in depression: a critical review.CNS Drugs. 2001 Jan;15(1):59-83. doi: 10.2165/00023210-200115010-00005. CNS Drugs. 2001. PMID: 11465013 Review.
-
Venlafaxine extended-release: a review of its use in the management of major depression.CNS Drugs. 2001;15(8):643-69. doi: 10.2165/00023210-200115080-00007. CNS Drugs. 2001. PMID: 11524036 Review.
-
Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein.Br J Clin Pharmacol. 1999 Sep;48(3):345-54. doi: 10.1046/j.1365-2125.1999.00031.x. Br J Clin Pharmacol. 1999. PMID: 10510145 Free PMC article. Clinical Trial.
-
[Sexual dysfunctions induced by serotonin reuptake inhibitors].Aten Primaria. 2000 Oct 15;26(6):389-94. doi: 10.1016/s0212-6567(00)78688-4. Aten Primaria. 2000. PMID: 11111311 Free PMC article. Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical